Drugs (BRUSSELS) – The European Commission opened Monday a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines.The investigation concerns the pricing…

The European Commission launched a public consultation Thursday with a view to assessing the scope and the content of a possible future initiative…